Other

Other income, net

Becton, Dickinson and Company Other income, net decreased by 32.0% to -$66.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 88.6%, from -$35.00M to -$66.00M. Over 4 years (FY 2021 to FY 2025), Other income, net shows a downward trend with a 16.7% CAGR.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2015
Last reportedQ2 2026May 7, 2026
Metric ID: other_other_operating_income_expense_net

Historical Data

20 periods
 Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Value$88.00M$0.00$4.00M$0.00-$11.00M-$30.00M-$3.00M-$4.00M$13.00M$203.00M-$11.00M$23.00M-$98.00M-$136.00M-$28.00M-$35.00M-$38.00M-$285.00M-$50.00M-$66.00M
QoQ Change-100.0%-100.0%-172.7%+90.0%-33.3%+425.0%>999%-105.4%+309.1%-526.1%-38.8%+79.4%-25.0%-8.6%-650.0%+82.5%-32.0%
YoY Change-112.5%-175.0%+218.2%+776.7%-266.7%+675.0%-853.8%-167.0%-154.5%-252.2%+61.2%-109.6%-78.6%-88.6%
Range-$285.00M$203.00M
CAGR-5.9%
Avg YoY Growth-37.7%
Median YoY Growth-111.0%

Business Segments

View all
SegmentQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q1 '26Q2 '26
Connected Care-$3.00M
BioPharma Systems$0.00
Interventional$0.00
Life Sciences-$1.50M$0.00$0.00$0.00$0.00$0.00$0.00
Medical Essentials$0.00
Total$203.00M-$11.00M$23.00M-$98.00M-$136.00M-$28.00M-$50.00M-$66.00M

Medical is derived from annual filings.

Life Sciences was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.

Frequently Asked Questions

What is Becton, Dickinson and Company's other income, net?
Becton, Dickinson and Company (BDX) reported other income, net of -$66.00M in Q1 2026.
How has Becton, Dickinson and Company's other income, net changed year-over-year?
Becton, Dickinson and Company's other income, net decreased by 88.6% year-over-year, from -$35.00M to -$66.00M.
What is the long-term trend for Becton, Dickinson and Company's other income, net?
Over 4 years (2021 to 2025), Becton, Dickinson and Company's other income, net has grown at a 16.7% compound annual growth rate (CAGR), from -$208.00M to -$386.00M.